FDA asks why Novartis took two months to launch formal internal probe, after AveXis flagged...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Aug 23, 2019 at 10:32 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    32,746
    Likes Received:
    3
    via And the plot thickens. Novartis $NVS officials are reportedly now scrambling to explain to the FDA why it took them two months to open an internal investigation into data discrepancies for their $2.1 million gene-therapy for spinal muscular dystrophy — the world’s most expensive drug.

    article source